Announced details
Livestock production, pig farming, maintaining the health and promoting the growth of weanling piglets, improving feed efficiency
Average daily gain tended to be higher during some periods. Feed conversion ratios were lower than in the control group in all euglena-supplemented groups, with the lowest value in the 0.05% group. In the 0.01% group, the number of CD8-positive cells increased significantly compared with the control group, and the number of MHC Class II-positive cells also tended to increase.
A study of 20 LWD-breed weanling piglets divided into 4 groups of 5 (number of subjects tested, not cumulative results or actual usage track record)
The University of Miyazaki, euglena Co., Ltd., and Asuka Animal Health Co., Ltd. jointly conducted the study and disclosed the research findings.
University of Miyazaki: Miyazaki, Miyazaki Prefecture; President: Samejima Hiroshi (鮫島 浩); a national comprehensive university. euglena Co., Ltd.: Head office in Minato-ku, Tokyo; Representative Director and President: Izumo Mitsuru (出雲 充). Asuka Animal Health Co., Ltd.: Head office in Minato-ku, Tokyo; Representative Director and President: Yamaguchi Fumiyasu (山口 文豊).
In this announcement the company addresses none of Contract Value / Offering price / Impact on Business Performance.
134th Annual Meeting of the Japanese Society of Animal Science; FAO, “Antimicrobial Resistance: Animal feeding”
| Item | Details |
|---|---|
| Names of Products / Services Covered | Feed containing euglena (feed formulated with euglena powder) |
| Counterparty | National University Corporation, University of Miyazaki, Euglena Co.,Ltd., Asuka Animal Health Co., Ltd. |
| Counterparty overview | University of Miyazaki: Miyazaki, Miyazaki Prefecture; President: Samejima Hiroshi (鮫島 浩); a national comprehensive university. euglena Co., Ltd.: Head office in Minato-ku, Tokyo; Representative Director and President: Izumo Mitsuru (出雲 充). Asuka Animal Health Co., Ltd.: Head office in Minato-ku, Tokyo; Representative Director and President: Yamaguchi Fumiyasu (山口 文豊). |
| Relationship with the Company | The University of Miyazaki, euglena Co., Ltd., and Asuka Animal Health Co., Ltd. jointly conducted the study and disclosed the research findings. |
| Applicable area | Livestock production, pig farming, maintaining the health and promoting the growth of weanling piglets, improving feed efficiency |
| Quantitative Effects | Average daily gain tended to be higher during some periods. Feed conversion ratios were lower than in the control group in all euglena-supplemented groups, with the lowest value in the 0.05% group. In the 0.01% group, the number of CD8-positive cells increased significantly compared with the control group, and the number of MHC Class II-positive cells also tended to increase. |
| Usage history | A study of 20 LWD-breed weanling piglets divided into 4 groups of 5 (number of subjects tested, not cumulative results or actual usage track record) |
| Source | 134th Annual Meeting of the Japanese Society of Animal Science; FAO, “Antimicrobial Resistance: Animal feeding” |
Items this document does not state (10)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To verify the potential for maintaining the health of fattening pigs and improving productivity in pig production.